Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Cell Surface Extensions
Novel strategy to reduce sudden-death risk in the healing phase after myocardial infarction.
Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling.
Utilizing CMP-Sialic Acid Analogs to Unravel Neisseria gonorrhoeae Lipooligosaccharide-Mediated Complement Resistance and Design Novel Therapeutics.
Walkey, Allan
See All 5 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Novel strategy to reduce sudden-death risk in the healing phase after myocardial infarction.
Donahue JK. Novel strategy to reduce sudden-death risk in the healing phase after myocardial infarction. Circulation. 2009 Jan 06; 119(1):6-8.
View in:
PubMed
subject areas
Death, Sudden, Cardiac
Humans
Myocardial Infarction
Risk Factors
Tachycardia
Wound Healing
authors with profiles
J. Kevin Donahue MD